Please login to the form below

Not currently logged in
Email:
Password:

hepatocellular carcinoma

This page shows the latest hepatocellular carcinoma news and features for those working in and with pharma, biotech and healthcare.

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

BMS has enjoyed its own, if slightly more moderate, success for Opdivo/Yervoy following additional approvals in melanoma, renal cell carcinoma, hepatocellular carcinoma and colorectal cancer.

Latest news

More from news
Approximately 2 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    This public-private research alliance is aimed at improving survival rates in hepatocellular carcinoma (the primary cancer of the liver).

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    Tislelizumab is in global phase III trials in a number of tumour types, including non-small cell lung cancer, hepatocellular carcinoma and oesophageal squamous cell carcinoma. ... It’s also in phase II trials in patients with previously treated

  • Deal Watch March 2016 Deal Watch March 2016

    Collaboration – discovery, development &commercialisation. $965. Exelixis/ Ipsen. Cabozantinib (Renal Cell Carcinoma, Hepatocellular Carcinoma, other indications) and Cometriq (medullary thyroid cancer).

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    120. 4SC AG/Menarini. Licensing and development agreement. Resminostat (oral HDAC) for hepatocellular carcinoma.

  • Pharma deals in April 2015 Pharma deals in April 2015

    deacetylase (HDAC) inhibitor in all oncological indications, in particular hepatocellular carcinoma in Asia Pacific (excluding Japan).

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...

Infographics